Five-Year Follow-up of Feedback Microwave Thermotherapy Versus TURP for Clinical BPH: A Prospective Randomized Multicenter Study-Reference-Cited by-同舟云学术

Five-Year Follow-up of Feedback Microwave Thermotherapy Versus TURP for Clinical BPH: A Prospective Randomized Multicenter Study

Published:2007-01 Issue:1 Volume:69 Page:91-96
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Mattiasson Anders,Wagrell Lennart,Schelin Sonny,Nordling Jorgen,Richthoff Jonas,Magnusson Bo,Schain Moddy,Larson Thayne,Boyle Emmett,Duelund-Jacobsen Jens,Kroyer Kurt,Ageheim Håkan

Publisher

Elsevier BV

Subject

Urology

Reference25 articles.

1. Concomitant longitudinal changes in frequency of and bother from lower urinary tract symptoms in community dwelling men;Sarma;J Urol,2002

2. Urologic diseases in America project: benign prostatic hyperplasia;Wei;J Urol,2005

3. Interventional therapy of benign prostatic hyperplasia;Djavan,2001

4. Transurethral microwave thermotherapy: the gold standard for minimally invasive therapies for patients with benign prostatic hyperplasia?;de la Rosette;J Endourol,2003

5. AUA guidelines on management of benign prostatic hyperplasia (2003), Chapter 1: diagnosis and treatment recommendations;J Urol,2003

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-inferiority, randomised, open-label clinical trial on the effectiveness of transurethral microwave thermotherapy compared to prostatic artery embolisation in reducing severe lower urinary tract symptoms in men with benign prostatic hyperplasia: study protocol for the TUMT-PAE-1 trial;Trials;2024-09-02

2. Transurethral microwave thermotherapy in men with prostates larger than 100 grams – A consecutive case series;2024-07-12

3. Non-inferiority, Randomised, Open-label Clinical Trial on the Effectiveness of Transurethral Microwave Thermotherapy Compared to Prostatic Artery Embolisation in Reducing Severe Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia: Study Protocol for the TUMT-PAE-1 Trial;2024-04-26

4. Cost-utility of minimally invasive therapies vs pharmacotherapy as initial therapy for benign prostatic hyperplasia: A Canadian healthcare payer perspective;Canadian Urological Association Journal;2022-12-06

5. Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study;Prostate Cancer and Prostatic Diseases;2022-06-10